Trexquant Investment’s IDEAYA Biosciences IDYA Stock Holding History

Trexquant Investment’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-56,275	Closed	-$1.53M	–	1738
2025 Q3	$1.53M	Buy	+56,275	New	+$1.36M	0.02%	1009
2025 Q2	–	Sell	-49,824	Closed	-$816K	–	1699
2025 Q1	$816K	Sell	49,824 -57,323	-53%	-$1.22M	0.01%	1152
2024 Q4	$2.75M	Buy	+107,147	New	+$3.03M	0.03%	745
2024 Q1	–	Sell	-21,984	Closed	-$782K	–	1584
2023 Q4	$782K	Buy	21,984 +5,432	+33%	+$162K	0.02%	909
2023 Q3	$447K	Sell	16,552 -34,687	-68%	-$880K	0.01%	1071
2023 Q2	$1.2M	Buy	+51,239	New	+$1.05M	0.03%	698
2022 Q2	–	Sell	-18,133	Closed	-$203K	–	1666
2022 Q1	$203K	Buy	+18,133	New	+$267K	0.01%	1195

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Trexquant Investment's IDYA Position: Q4 2025 in Review

Trexquant Investment sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 56,275 shares — an estimated $1.53M sold.

Trexquant Investment first reported a position in IDYA in Q1 2022 and held it in 7 quarters. The position peaked at $2.75M in Q4 2024. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

Trexquant Investment reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
Trexquant Investment sold 56,275 IDEAYA Biosciences shares in Q4 2025, an estimated $1.53M.
Trexquant Investment first reported a position in IDEAYA Biosciences in Q1 2022 and held it in 7 quarters.
Trexquant Investment's IDEAYA Biosciences position peaked at $2.75M in Q4 2024.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.